EWM
BTX.WS

Endurance Wealth Management’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Endurance Wealth Management’s Portfolio BTX.WS Stock Details BTX.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-19
Closed – – 539
2015
Q3 		$0 Hold
19
– – ﹤0.01% 545
2015
Q2 		$0 Buy
+19
New +$36 ﹤0.01% 536

Other funds holding BTX.WS

ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $25.9B AUM 26.38% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMS
Bellevue Asset Management (Switzerland) Kuesnacht, Switzerland $656M AUM 11.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Endurance Wealth Management's BTX.WS Position: Q4 2015 in Review

Endurance Wealth Management sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q4 2015, closing a stake of 19 shares.

Endurance Wealth Management first reported a position in BTX.WS in Q2 2015 and held it in 2 quarters. The position peaked at $0 in Q3 2015. 40 funds tracked by Wall St. Rank hold BTX.WS as of Q4 2015.

  • Endurance Wealth Management reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q4 2015 after selling out during the quarter.
  • Endurance Wealth Management sold 19 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q4 2015.
  • Endurance Wealth Management first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q2 2015 and held it in 2 quarters.
  • Endurance Wealth Management's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $0 in Q3 2015.
  • 40 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q4 2015.

Based on Endurance Wealth Management's 13F filing for Q4 2015, filed 27 Jan 2016.